Biotech grants in Ireland

Closed

Funds research consortia developing the pre-normative science behind future standards for bio-based chemicals, polymers and other bio-based products.

Closed

Funds one €20M industrial project that scales biotechnology into sustainable biorefineries and market-ready bio-based products.

Closed

Funds two €7M projects that make durable products from renewable feedstocks and give cross-linked plastics viable recycling, reuse or upcycling routes.

Closed

Funds three €4M lump-sum grants for industrial and environmental biotech — synthetic biology, gene editing, biofoundries — not health biotech or biofuels.

Closed

Funds two €5M projects turning marine organisms — algae, fungi, invertebrates — into safer bio-based replacements for adhesives, coatings and chemicals.

Closed

Funds two €7M projects that turn farm, forestry, aquatic and urban bio-waste into market-ready chemicals, materials and ingredients.

Closed

Funds one €20M industrial project making safe bio-based fertilisers or crop-protection products that work in real fields.

Closed

Funds consortia to cut cost, solvent use, energy and water in biorefineries, tested across at least three industrial or demo-scale use cases.

Closed

Funds two €7M projects turning bark, sawdust and other woody residues into validated bio-based chemicals or materials for sustainable end products.

Closed

Funds two €3.25M projects that turn alternative bio-feedstocks into safe, circular polymers tested across at least two markets.

Closed

Funds two €3.25M projects that turn sustainable biomass or bio-based textile waste into high-performing, circular fibres.

Closed

Funds consortia developing biotech and nature-based decontamination methods for war-damaged land, water and air, proven on real sites in Ukraine.

Closed

Funds rare-disease research calls, clinical trial networks and shared data for ERDERA's second phase — open only to the existing coordinator.

Closed

Funds research consortia, including businesses and startups, that study microbiomes across plants, humans and environments to unlock new food-system applications.

Closed

Funds one project to standardise beta-cell manufacturing, immune-tolerance strategies and clinical criteria that speed up cell therapy for type 1 diabetes.

Closed

Funds one consortium to run a microbiome research one-stop-shop and coordination hub for EU policymakers and regulators.

Closed

Funds R&D that turns existing food-safety science — molecular methods, genomics, photonics — into deployable tools against food fraud and safety risks.

Closed

Funds development of lab-grown human tissue models, organ-on-chip systems and AI-driven simulations that can replace animal testing in drug and medical device development.

Closed

Funds late-stage development of new diagnostic tests for vector-borne diseases such as those spread by mosquitoes and ticks.

Closed

Funds companies and researchers scaling up precision-fermentation microorganisms that turn captured CO2 into food nutrients.

Closed

Funds AU-EU research consortia developing locally-produced therapeutic and supplementary foods for child malnutrition in Africa.

Closed

Funds industry-academia consortia that refine and scale up the manufacturing process for one class of cell or gene therapy, from quality control through to deployment.

Closed

Funds research into the prevention, diagnosis and treatment of long-term health conditions that persist after a viral, bacterial, parasitic or fungal infection has cleared.

Closed

Administers research teams and institutions for PRECISEU Joint Interregional Projects on Personalised Medicine in medical technology, biotechnology, and artificial intelligence.